News Events

COVID-19 Business Update as of 25th March 2022 – We’re here to help you stay on track

25 March 2022 - Cardiff, UK

We would like to reassure all our small molecule innovator partners of some of our measures in place to continue safely enabling the progression of your drug development projects. A number of contingency measures have been implemented to mitigate both the probability and impact of a COVID-19 outbreak disrupting our ability to continue to provide you with vital tailored chemistry services.

Learn more

CatSci Appoints New Director of Pharmaceutical Development, Dr Gary Parsons

22 March 2022 - Cardiff, UK

CatSci is proud to announce the appointment of Dr Gary Parsons as their new Director of Pharmaceutical Development.

Learn More

CatSci Secures Major £4.5m Funding Deal

16 March 2022 - Cardiff, UK

CatSci is delighted to announce that we have secured a major £4.5m funding deal from the alternative lender BOOST&Co to expedite the development and launch of life-changing therapeutics.

Learn More

CatSci Appoints New Director of Chemical Development, Rob Crook

09 March 2022 - Cardiff, UK

CatSci is proud to announce the appointment of Robert Crook as their new Director of Chemical Development as they continue to evolve their capabilities.

Learn More

CatSci Shortlisted As Finalists For The Bionow Export Of The Year Award

25 February 2022 - Cardiff, UK

We are proud to share that we have been selected as finalists for Bionow Awards 2022 Export of the Year Award.

Learn More

What’s Next For CatSci In 2022

14 January 2022 - Cardiff, UK

Year on year, CatSci continues to evolve. We have big plans for 2022, including enhancing our capabilities, growing our team and expanding our facilities. You can read all about what 2022 has in store for CatSci here...

Learn More